Related Experiment Video

Updated: Aug 15, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Experimental pneumococcal meningitis. IV. The effect of methyl prednisolone on meningeal inflammation

C M Nolan, C K McAllister, E Walters

    The Journal of Laboratory and Clinical Medicine
    |June 1, 1978
    PubMed

    Insights

    Adrenal corticosteroids like methylprednisolone reduce inflammation in experimental pneumococcal meningitis. This effect appears linked to inhibiting granulocyte adherence, not altering cerebrospinal fluid activity.

    Area of Science:

    • Neuroscience
    • Immunology
    • Pharmacology

    Background:

    • Bacterial meningitis, particularly pneumococcal meningitis, triggers significant meningeal inflammation.
    • Inflammation involves granulocyte infiltration and activation in the cerebrospinal fluid (CSF) and meninges.
    • The role of corticosteroids in modulating this inflammatory response requires further elucidation.

    Purpose of the Study:

    • To investigate the efficacy of adrenal corticosteroids in suppressing meningeal inflammation in a rabbit model of pneumococcal meningitis.
    • To determine if corticosteroid-mediated suppression involves alterations in CSF chemotactic activity or granulocyte responses.
    • To explore the specific mechanisms by which methylprednisolone impacts the inflammatory cascade.

    Main Methods:

    • Induction of experimental pneumococcal meningitis in rabbits.
    • Intramuscular administration of methylprednisolone at doses of 15 or 30 mg/kg at 24 and 48 hours post-infection.
    • Quantification of meningeal granulocyte mass at 72 hours post-infection.
    • Assessment of CSF chemotactic activity and granulocyte chemotaxis, phagocytosis, and adherence.

    Main Results:

    • Methylprednisolone significantly reduced meningeal granulocyte mass in a dose-dependent manner (p < 0.01).
    • Higher doses (30 mg/kg) showed approximately twice the suppressive effect of lower doses (15 mg/kg) (p < 0.05).
    • Steroid therapy did not alter CSF chemotactic activity or granulocyte responsiveness but inhibited the increase in granulocyte adherence observed in untreated meningitis.

    Conclusions:

    • Adrenal corticosteroids, specifically methylprednisolone, effectively suppress meningeal inflammation in experimental pneumococcal meningitis.
    • The anti-inflammatory mechanism appears to be mediated, at least in part, by the inhibition of granulocyte adherence.
    • These findings suggest a potential therapeutic role for corticosteroids in managing bacterial meningitis-associated inflammation.

    More Related Videos

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

    Published on: May 7, 2020

    Related Concept Videos

    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...